Billy Caldwell, diagnosed with severe epilepsy as an infant, was initially not expected to survive past his first birthday. Medical professionals struggled to control his daily seizures through conventional pharmaceutical interventions. His mother, Charlotte, described how Billy was eventually kept alive through a combination of medications but continued to experience significant medical challenges, including episodes of hundreds of seizures daily. His condition left him tube-fed and unable to stand independently.
In an effort to find alternative treatments, the family consulted a specialist in Chicago in 2010, who adjusted Billy’s medical regimen and diet. By June 2016, when Billy was nearly 11 years old, his condition deteriorated again. A medical cannabis expert then recommended treatment with cannabidiol (CBD), a non-psychoactive compound derived from cannabis plants. Following this intervention, Billy’s symptoms improved significantly.
The family faced legal obstacles upon returning to Northern Ireland, as NHS prescriptions for cannabis-based treatments were not permitted without clinical trial evidence at that time. After obtaining CBD through a Canadian specialist and attempting to bring it into the UK, customs officials at Heathrow Airport confiscated the medicine. Billy subsequently experienced a severe seizure and required emergency hospitalization. Public attention to the case prompted government intervention, and the Conservative government granted the family a special license for cannabis oil treatment.
Following this decision, the government relaxed its regulatory framework for cannabis-derived medicines. Billy began receiving treatment through the NHS and experienced a cessation of seizures. His condition remained stable except for a brief relapse in 2023 due to a temporary supply disruption. Charlotte Caldwell noted that Billy has since regained mobility, improved balance, and can now navigate stairs independently.
While celebrating her son’s survival and progress, Charlotte has raised concerns about ongoing barriers to cannabis-based treatment access. She founded an advocacy organization called TRACD to address what she describes as overly restrictive NHS prescribing practices that force many patients toward expensive private treatment options.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI